MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

    KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To analyze the construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: The MDS-NMS is a new instrument that…
  • 2019 International Congress

    Prevalence of orthostatic hypotension and postprandial hypotension in neurodegenerative diseases with synucleinopathy: a systematic review and meta-analysis

    CS. Chuang, SL. Wu (Changhua, Taiwan)

    Objective: This study aimed to evaluate the prevalence of orthostatic hypotension (OH) and postprandial hypotension (PPH) in patients with Parkinson's disease (PD), multiple system atrophy…
  • 2019 International Congress

    Mandibular Advancement Device in Parkinson’s disease: an efficacious and usable device in a disabling disease

    V. Cochen Decock, M. Castel, I. Bonafé (Montpellier, France)

    Objective: The aim of our study is to explore the efficacy, observance, and usability of Mandibular Advancement Device in patients with  Parkinson’s disease (PD) and…
  • 2019 International Congress

    The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease

    H. Combs, A. Strutt, J. Jimenez-Shahed, N. Niemann, A. Viswanathan, M. York (Houston, TX, USA)

    Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…
  • 2019 International Congress

    Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease

    M. Cordellini, A. Machado, C. Costa (Curitiba, Brazil)

    Objective: Evaluation of patients with idiopathic Parkinson's disease regarding the presence of RBD, application of the questionnaires, and correlation between the diagnosis of RBD by…
  • 2019 International Congress

    Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease

    H. Dafsari, S. Jost, A. Sauerbier, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, P. Löhrer, A. Rizos, JN. Petry-Schmelzer, G. Fink, M. Barbe, A. Antonini, P. Martinez-Martin, K. Ray-Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of sleep, depression, and quality of life (QoL) compared…
  • 2019 International Congress

    Prospective Memory in Parkinson’s Disease: the role of the motor subtypes

    A. D'Iorio, G. Maggi, C. Vitale, D. Di Meglio, L. Trojano, G. Santangelo (Caserta, Italy)

    Objective: In the present study, we evaluated whether deficits in Prospective memory (PM) abilities were present to the same extent in tremor dominant patients with…
  • 2019 International Congress

    Instrumental evaluation of sleep disturbance and autonomic nervous system dysfunction in idiopathic Parkinson’s disease

    MD. Doręgowska, MT. Toś, JM. Malkiewicz, JS. Siuda, MR. Rudzińska-Bar (Katowice, Poland)

    Objective: The aim of the study was the instrumental evaluation of occurrence and intensity of autonomic and sleep disturbances in patients with idiopathic PD. Background:…
  • 2019 International Congress

    Deep Brain Stimulation of Subthalamic Nucleus (DBS-STN) in Parkinson Disease (PD): Acute Clinical Effects in Hypothalamic control

    D. Dos Santos, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: Objectives: To evaluate the impact of acute STN-DBS on the autonomic nervous system through clinical validated scales (SCOPA-AUT and PDSS). Background: Background: Several studies point…
  • 2019 International Congress

    Non-motor Symptoms in Hyperkinetic Movement Disorders

    H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: To evaluate the frequencies and clinical features of non-motor symptoms in several different hyperkinetic movement disorders and compare them with the healthy age- and…
  • « Previous Page
  • 1
  • …
  • 1176
  • 1177
  • 1178
  • 1179
  • 1180
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley